[HTML][HTML] Novel approaches for vaccine development

MS Gebre, LA Brito, LH Tostanoski, DK Edwards… - Cell, 2021 - cell.com
Vaccines are critical tools for maintaining global health. Traditional vaccine technologies
have been used across a wide range of bacterial and viral pathogens, yet there are a …

Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment

A Allué-Guardia, JI García, JB Torrelles - Frontiers in Microbiology, 2021 - frontiersin.org
In the last two decades, multi (MDR), extensively (XDR), extremely (XXDR) and total (TDR)
drug-resistant Mycobacterium tuberculosis (M. tb) strains have emerged as a threat to public …

Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19

KTL Sy, NJL Haw, J Uy - Infectious Diseases, 2020 - Taylor & Francis
Background There is a growing literature on the association of SARS-CoV-2 and other
chronic conditions, such as noncommunicable diseases. However, little is known about the …

Drug resistant Tuberculosis: A review

JL Khawbung, D Nath, S Chakraborty - … immunology, microbiology and …, 2021 - Elsevier
Tuberculosis (TB) was announced as a global emergency in 1993. There was an alarming
counter attack of TB worldwide. However, when it was known that TB can be cured …

Extrapulmonary tuberculosis—an update on the diagnosis, treatment and drug resistance

R Gopalaswamy, VNA Dusthackeer, S Kannayan… - Journal of …, 2021 - mdpi.com
Pathogenic Mycobacterium tuberculosis complex organisms (MTBC) primarily cause
pulmonary tuberculosis (PTB); however, MTBC are also capable of causing disease in …

Variation of tuberculosis prevalence across diagnostic approaches and geographical areas of Indonesia

A Noviyani, T Nopsopon, K Pongpirul - PLoS One, 2021 - journals.plos.org
Background Tuberculosis (TB) has contributed to a significant disease burden and
economic loss worldwide. Given no gold standard for diagnosis, early identification of TB …

Drug-resistant tuberculosis 2020: where we stand

A Iacobino, L Fattorini, F Giannoni - Applied Sciences, 2020 - mdpi.com
Featured Application This comprehensive overview of drug-resistant tuberculosis will be
useful for researchers to expand their knowledge beyond mechanisms other than …

Niosome as an effective nanoscale solution for the treatment of microbial infections

M Barani, F Paknia, M Roostaee… - BioMed Research …, 2023 - Wiley Online Library
Numerous disorders go untreated owing to a lack of a suitable drug delivery technology or
an appropriate therapeutic moiety, particularly when toxicities and side effects are a major …

Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance

S Perveen, D Kumari, K Singh, R Sharma - European Journal of Medicinal …, 2022 - Elsevier
The emergence of drug resistance continues to afflict TB control where drug resistant strains
have become a global health concern. Contrary to drug-sensitive TB, the treatment of …

“Big Three” infectious diseases: tuberculosis, malaria and HIV/AIDS

P Makam, R Matsa - Current Topics in Medicinal Chemistry, 2021 - ingentaconnect.com
Infectious diseases have been evolving and re-evolving over the ages and causing
immense misery to humans. Among them, some have been prevented and eradicated, but …